Mapping Lung Squamous Cell Carcinoma Pathogenesis Through In Vitro and In Vivo Models

Scientists discuss how molecular profiling of premalignant lesions and invasive lung squamous cell carcinoma (LUSC) has contributed to the refinement of in vitro and in vivo models, and in turn, how these systems have increased our understanding of LUSC biology and therapeutic vulnerabilities.